SAN DIEGO, March 3 /PRNewswire/ -- Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. announced today that they have entered into an exclusive license and distribution agreement in which Sanofi-Aventis Deutschland will have the right to commercialize and market Novalar’s OraVerse in Germany with options to extend the license to additional European countries. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to dentists.
“Sanofi-Aventis is a leading pharmaceutical company in Germany with a strong dental franchise. We are eager to add OraVerse to our portfolio of product offerings, which includes our market-leading local anesthetic Ultracain(R),” said Peter Guenter, General Manager Commercial Operations at Sanofi-Aventis Deutschland. “This collaboration provides us with an opportunity to launch a first-in-class dental product in Germany.”
About OraVerse(R)
OraVerse (phentolamine mesylate) Injection is the first and only local dental anesthesia reversal agent that accelerates the return to normal sensation and function following restorative and periodontal maintenance procedures. OraVerse is indicated for the reversal of soft tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. OraVerse is indicated for use only in adults and children 6 years of age or older and weighing at least 15 kg (33 lbs). For more information visit www.oraverse.com.
CONTACT: Derek Kelaita, Director, Corporate Development, Novalar
Pharmaceuticals, Inc., +1-858-436-1100, kelaita@novalar.com; or Media and
Investors, Jason Spark, Vice President of Porter Novelli Life Sciences,
+1-619-849-6005, jspark@pnlifesciences.com, for Novalar Pharmaceuticals,
Inc.
Web site: http://www.novalarpharm.com/
http://www.oraverse.com/
